Genelux (GNLX) Announces Management Changes

Go back to Genelux (GNLX) Announces Management Changes

Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires

July 20, 2023 4:45 PM UTC

WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced two key management promotions, as well as the addition of two new members to its leadership team. Joseph Cappello, Ph.D., who previously served as the Companys Vice President of Pharmaceutical Development, has been promoted to Chief... More